Emerging Autism Therapeutics: Focus on MSC-EVs Exploring Mesenchymal Stem Cell-derived Extracellular Vesicles as a Potential Treatment for Autism — What are Mesenchymal stem cells (MSCs)? Mesenchymal stem cells (MSCs), a type of adult stem cell found in various tissues throughout the body,...
Repurposing Existing Drugs for Autism Unlocking the hidden potential of existing, FDA-approved drugs to treat autism At the BRAIN Foundation we were recently thrilled to announce a groundbreaking collaboration with Every Cure, a nonprofit organization dedicated to identifying new uses for existing...
BRAIN Foundation 5k 10k Run & 1 Mile Walk – September 2024 We are delighted to report that the first EVER Brain Foundation Run/Walk Fundraiser was a great success. Thank you to everyone who joined, volunteered, sponsored, donated and contributed in other ways to make this such a...
Call for Autism Case Studies Calling all physicians! If you are a specialist treating a patient with autism with comorbidities and are using any of the next generation drugs like: MAB drugs like Humira/Enbrel/Stelara mTOR inhibitors like sirolimus and everolimus JAK inhibitors like Rinvoq and...
Synchrony 2023 Research & Clinical Presentations Recordings of Synchrony 2023 presentations now available to watch here 🎥 Synchrony 2023 was an in-person event held on Oct 20-22 at the Asilomar Conference Grounds, California, with the speaker line up that included leading academics, clinical...
JelikaLite to Launch Autism Therapy Device, Offers Early Access Waitlist JelikaLite has announced limited supply of the Cognilum device at its anticipated launch in 2024 and invites early sign-up in order to guarantee access as well as the exclusive waitlist discount. In addition, if you apply to...